Annual Drug Patent Expirations for BRUKINSA
Brukinsa is a drug marketed by Beigene and is included in one NDA. There are three patents protecting this drug.
This drug has thirty-six patent family members in twenty-five countries.
The generic ingredient in BRUKINSA is zanubrutinib. Additional details are available on the zanubrutinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
